Elezanumab

DB15240Investigational

Elezanumab is under investigation in clinical trial NCT03737812 (A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis).

Mechanism: Pharmacologically active on Repulsive guidance molecule A
Curator reviewed
Code names: ABT-555

Resolves to

Compound

UNIISK1LVT23A1CAS1791416-49-3

Targets

Q96B86RGMA

What you can answer from here — as of May 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Elezanumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account